Classification accuracy of TMS for the diagnosis of mild cognitive impairment.
Benussi, A; Grassi, M; Palluzzi, F; Cantoni, V; Cotelli, MS; Premi, E; Di Lorenzo, F; Pellicciari, MC; Ranieri, F; Musumeci, G; Marra, C; Manganotti, P; Nardone, R; Di Lazzaro, V; Koch, G; Borroni, B
BRAIN STIMUL. 2021; 14(2): 241-249.
Originalarbeiten (Zeitschrift)

Diagnosing Fracture-Related Infection: Current Concepts and Recommendations.
Govaert, GAM; Kuehl, R; Atkins, BL; Trampuz, A; Morgenstern, M; Obremskey, WT; Verhofstad, MHJ; McNally, MA; Metsemakers, WJ;
J Orthop Trauma. 2020; 34(1): 8-17.
Originalarbeiten (Zeitschrift)

Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
Scharmann, U; Verhasselt, HL; Kirchhoff, L; Buer, J; Rath, PM; Steinmann, J; Ziegler, K;
Mycoses. 2020; 63(12):1362-1367
Originalarbeiten (Zeitschrift)

Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.
Hamed, S; Behnes, M; Pauly, D; Lepiorz, D; Barre, M; Becher, T; Lang, S; Akin, I; Borggrefe, M; Bertsch, T; Hoffmann, U;
BMC Infect Dis. 2017; 17(1): 554
Originalarbeiten (Zeitschrift)

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Höglinger, GU; Respondek, G; Stamelou, M; Kurz, C; Josephs, KA; Lang, AE; Mollenhauer, B; Müller, U; Nilsson, C; Whitwell, JL; Arzberger, T; Englund, E; Gelpi, E; Giese, A; Irwin, DJ; Meissner, WG; Pantelyat, A; Rajput, A; van Swieten, JC; Troakes, C; Antonini, A; Bhatia, KP; Bordelon, Y; Compta, Y; Corvol, JC; Colosimo, C; Dickson, DW; Dodel, R; Ferguson, L; Grossman, M; Kassubek, J; Krismer, F; Levin, J; Lorenzl, S; Morris, HR; Nestor, P; Oertel, WH; Poewe, W; Rabinovici, G; Rowe, JB; Schellenberg, GD; Seppi, K; van Eimeren, T; Wenning, GK; Boxer, AL; Golbe, LI; Litvan, I;
Mov Disord. 2017; 32(6): 853-864.
Originalarbeiten (Zeitschrift)

Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.
Stättermayer, AF; Traussnigg, S; Aigner, E; Kienbacher, C; Huber-Schönauer, U; Steindl-Munda, P; Stadlmayr, A; Wrba, F; Trauner, M; Datz, C; Ferenci, P;
J Trace Elem Med Biol. 2017; 39: -107.
Originalarbeiten (Zeitschrift)

The utility of biomarker risk prediction score in patients with chronic heart failure.
Berezin, AE; Kremzer, AA; Martovitskaya, YV; Berezina, TA; Samura, TA;
Clin Hypertens. 2015; 22:3
Originalarbeiten (Zeitschrift)

[The diagnostic value of nuclear magnetic resonance tomography, multimodal evoked potentials and cerebrospinal fluid examination in multiple sclerosis].
Staffen, W; Trinka, E; Ladurner, G;
Nervenarzt. 1993; 64(4): 226-232.
Originalarbeiten (Zeitschrift)